Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Preparation of amino acid-based hydroxamic acids as histone deacetylase (HDAC) inhibitors
Smiles: CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(N)=O
CAS Number: 28342-31-6
Tideglusib prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders
InChiKey: QRFDENJATPJOKG-KPKJPENVSA-N
Hydroxypyruvic acid lithium hydrate Size:Contact [email protected] for quotation Preparation of amino acid-based hydroxamicHydroxypyruvic acid lithium hydrate ( Hydroxypyruvic acid lithium hydrate) is an intermediate in the metabolism of glycine, serine and threonine. Hydroxypyruvic acid lithium hydrate is a substrate for serine pyruvate aminotransferase and glyoxylate reductase hydroxypyruvate reductase. Hydroxypyruvic acid lithium hydrate is involved in the metabolic disorder which is the dimethylglycine dehydrogenase deficiency pathway. Product information CAS Number:
US$ 123.99
US$ 140.00
US$ 185.00